BPIQ Blog

Nov 14, 20194 min read

AMRN - Near-Term Price Acton Depends on Breadth of Label, but Acquisition Chatter and Quarterly Resu

Today, an advisory committee appointed by the FDA met and voted to recommend to the FDA that it expands the label for AMRN's...

Mar 1, 20192 min read

HZNP Reports Excellent Phase 3 Data for Thyroid Eye Disease

Congrats to Horizon Pharma (HZNP) and especially patients with thyroid eye disease (TED), on the positive phase 3 results reported...

Jul 1, 20181 min read

ZGNX imminently releasing more Ph3 data in a severe form of childhood epilepsy

Zogenix (ZGNX) is set to imminently release additional phase 3 data from its trial with its drug ZX008 (low dose fenfluramine) for...

Jun 23, 20181 min read

GBT's Part A Phase 3 Sickle Cell Data - Any Day Now

Looking forward to Global Blood Therapeutics report out of Part A from their Phase 3 Hope study of their drug voxelotor (formerly GBT440)...

Jump start your biotech due diligence

Our platform helps you uncover your next biotech investment opportunity